[1]Glaziou P, Falzon D, Floyd K, et al. Global epidemiology of tuberculosis. Semin Respir Crit Care Med, 2013, 34(1):3-16.[2]Donnelly JJ, Ulmer JB, Shiver JW, et al. DNA vaccines. Annu Rev Immunol,1997,15:617-648.[3]Meyer J, McShane H. The next years for tuberculosis vaccines: do we have the right plans in place? Expert Rev Vaccines,2013,12(4):443-451.[4]MacGregor R, Boyer J, Ugen K, et al. First human trial of a DNA based vaccine for treatment of human immunodeficiency virus type 1 infection: Safety and host response. J Infect Dis,1998,178(1): 92-100.[5]Liu MA, McClements W, Ulmer JB, et al. Immunization of non-human primates with DNA vaccine. Vaccine,1997,15(8): 909-912.[6]Tacket CO, Roy MJ, Widera G, et al. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine,1999,17 (22): 2826-2829.[7]Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol,2000,18:927-974.[8]Sardesai NY, Weiner DB. Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol,2011,23(3):421-429.[9]Liu KH, Ascenzi MA, Bellezza CA, et al. Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks. J Virol,2011,85(10):4853-4862.[10]Barbon CM1, Baker L, Lajoie C, et al. In vivo electroporation enhances the potency of poly-lactide co-glycolide (PLG) plasmid DNA immunization. Vaccine,2010,28(50):7852-7864.[11]Zupanic A, Corovic S, Miklavcic D, et al. merical optimization of gene electrotransfer into muscle tissue. Biomed Eng Online,2010,9:66.[12]Denis O, Tanghe A, Palfliet K, et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T cell epitopic repertoire broader than that stimulated by M. tuberculosis H37Rv infection. Infect Immun,1998,6(4):1527-1533.[13]吴雪琼,张俊仙,李洪敏,等. 结核分枝杆菌Ag85A DNA 疫苗免疫治疗作用的研究. 中国免疫学杂志,2002,18(1):17-22.[14]Liang Y, Wu XQ, Zhang JX, et al.The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine,2008,26(35):4536-4540.[15]Liang Y, Wu X, Zhang J, et al. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs. Scand J Immunol,2011,74(1):42-46.[16]梁艳,吴雪琼,张俊仙,等. 结核分枝杆菌Ag85A DNA 疫苗抗结核作用的研究. 中国防痨杂志,2012,34(3):181-183.[17]Ha SJ, Jeon BY, Kim SC, et al. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Therapy,2003,10(18):1592-1599.[18]Lowrie DB, Tascon RE, Bonato VLD, et al. Therapy of tuberculosis in mice by DNA vaccination. Nature,1999,400(6741):269-271.[19]Huygen K, Content J, Denis O, et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med,1996,2(8):893-898.[20]华瑞,华芳,陈海美,等. 电穿孔法增强HBV DNA疫苗免疫效果的评价. 吉林大学学报(医学版),2008,34(2):347-350.[21]李鼎锋,张玉伟,李海山,等. 体内电穿孔对报告基因表达和HIV Gag DNA 疫苗诱导的免疫反应的影响. 中华微生物学和免疫学杂志,2006,26(11):1038-1041.[22]Derrick SC, Repique C, Snoy P, et al. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect Immun,2004,72(3):1685-1692.[23]Green AM, Difazio R, Flynn JL. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol,2013,190(1):270-277.[24]Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol,2001,19:93-129.[25]Munk ME, Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur Respir J,1995,20(Suppl):S668-675. |